Verastem data on ovarian cancer drug combo set for IGCS 2026

Go back to Verastem data on ovarian cancer drug combo set for IGCS 2026
VERASTEM SHS (NASDAQ: VSTM) Delayed: 10.06 +0.85 (9.23%)
Previous Close $9.21    52 Week High $2.43 
Open $9.20    52 Week Low $1.05 
Day High $10.11    P/E N/A 
Day Low $9.14    EPS $-1.79 
Volume 5,947,212